Phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in patients with cT3-T4a and/or node-positive advanced adenocarcinoma of the esophagogastric junction: Primary endpoint results of the ESOX trial.
Phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in patients with cT3-T4a and/or node-positive advanced adenocarcinoma of the esophagogastric junction: Primary endpoint results of the ESOX trial.
复制标题
对 cT3-T4a 和/或食管胃交界部淋巴结阳性晚期腺癌患者进行 S-1 加奥沙利铂全身化疗随后进行手术的 II 期研究：ESOX 试验的主要终点结果。
DOI：
--
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Shinji Min
中科院分区：
文献类型：
--
作者：
Yu Imamura;Keisho Chin;Takahiro Tsushima;Yasuhiro Tsubosa;Hiroki Hara;Takashi Fukuda;Motoo Nomura;Shigeru Tsunoda;Takashi Ogata;Tsutomu Hayashi;Yoshihiro Nabeya;Keiko Minashi;Hidekazu Kuramochi;Mie Hamano;Ayako Doi;Shinya Mikami;Shinji Min
